CencoraSTU:ABG +0.60%68 FCF Margin % is 1.50% as of Mar. 2026, which is 49% above its 10-year median of 1.01. GuruFocus rates STU:ABG with a GF Score™ of 68/100 and a GF Value™ of €257.11 (Fairly Valued). The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, Cencora ranks worse than 55.08% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cencora's Free Cash Flow for the
three
months ended in Mar. 2026 was €1,015 Mil. Cencora's Revenue for the
three
months ended in Mar. 2026 was €67,778 Mil. Therefore, Cencora's FCF Margin % for the quarter that ended in Mar. 2026 was 1.50%.
The historical rank and industry rank for Cencora's FCF Margin % or its related term are showing as below:
STU:ABG'
s FCF Margin % Range Over the Past 10 Years
Min: 0.47 Med: 1.01 Max: 1.85
Current: 0.47
During the past 13 years, the highest FCF Margin % of Cencora was 1.85%. The lowest was 0.47%. And the median was 1.01%.
STU:ABG's FCF Margin % is ranked worse than 55.08% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs STU:ABG: 0.47
Cencora FCF Margin % Related Terms
Cencora FCF Margin % Historical Data
* Premium members only.
The historical data trend for Cencora's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:ABG vs CAH, MCK, HSIC: FCF Margin % Comparison
For the Medical Distribution subindustry, Cencora's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Cencora's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (STU:ABG) has a FCF Margin % of 1.50% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cencora and its competitors. This is 49% above median its historical median of 1.01. Over the past decade, Cencora's FCF Margin % has ranged from 0.47 to 1.85. According to the industry distribution chart, Cencora ranks #65 out of 118 companies in the Medical Distribution industry, placing it in the top 55.1%.
Is Cencora's FCF Margin % too high?
Cencora's current FCF Margin % of 1.50% is 49% above median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 1.85. The Medical Distribution industry median FCF Margin % is 1.06. Cencora's value of 1.50% is 41.5% above this industry median. Based on the distribution chart, Cencora ranks #65 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cencora has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's FCF Margin % compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #65 out of 118 companies for FCF Margin %. This places Cencora in the lower half of its industry. The industry median FCF Margin % is 1.06. Cencora's value of 1.50% is 41.5% above this benchmark. Historically, Cencora's own FCF Margin % has ranged from 0.47 to 1.85 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 1.06, Cencora has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current FCF Margin % of 1.50% is 41.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current FCF Margin % is 1.50%, which is 49% above median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (STU:ABG) is currently considered Fairly Valued. The stock's GF Value™ is €257.11, compared to a current price of €252.70 — trading 1.7% below its estimated fair value. The current FCF Margin % is 1.50%, which is 49% above median its 10-year median of 1.01 and 41.5% above the Medical Distribution industry median of 1.06. Cencora's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cencora (STU:ABG), the current FCF Margin % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (STU:ABG) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €252.70 is trading 1.7% below its estimated GF Value™ of €257.11.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for STU:ABG:
FCF Margin %: 1.50% (49% above median its 10-year median of 1.01)
GF Value™: €257.11 vs. price of €252.70 (1.7% below fair value)
Industry Position: 41.5% above the Medical Distribution median (#65 of 118)
No single metric tells the full story. See the STU:ABG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score
Get the complete analysis for STU:ABG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:ABG has been successfully added to your 
